Rating History for Akebia Therapeutics (AKBA) by Leerink
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/7/2026 | Roanna Ruiz | Downgrade | Market Perform (Outperform) |
1.00 (N/A) |
0.95 (0.98) |
3.16% | Details |
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/7/2026 | Roanna Ruiz | Downgrade | Market Perform (Outperform) |
1.00 (N/A) |
0.95 (0.98) |
3.16% | Details |
![]() |
|||||||
![]() |
|||||||